Transdermal nicotine patch adherence

Greater adherence to transdermal nicotine patch use was significantly associated with higher odds of achieving smoking abstinence at end of treatment.

Effect: improvement; OR 1.06 per patch used; CI: 95% CI: 1.03-1.08

Greater adherence to transdermal nicotine patch use was significantly associated with higher odds of achieving smoking abstinence at end of treatment.

Effect: improvement; OR 1.06 per patch used; CI: 95% CI: 1.03-1.08

Greater adherence to transdermal nicotine patch use was significantly associated with higher odds of achieving smoking abstinence at end of treatment.

Effect: improvement; OR 1.06 per patch used; CI: 95% CI: 1.03-1.08

Greater adherence to transdermal nicotine patch use was significantly associated with higher odds of achieving smoking abstinence at end of treatment.

Effect: improvement; OR 1.06 per patch used; CI: 95% CI: 1.03-1.08

Greater adherence to transdermal nicotine patch use was significantly associated with higher odds of achieving smoking abstinence at end of treatment.

Effect: improvement; OR 1.06 per patch used; CI: 95% CI: 1.03-1.08

Greater adherence to transdermal nicotine patch use was significantly associated with higher odds of achieving smoking abstinence at end of treatment.

Effect: improvement; OR 1.06 per patch used; CI: 95% CI: 1.03-1.08

Greater adherence to transdermal nicotine patch use was significantly associated with higher odds of achieving smoking abstinence at end of treatment.

Effect: improvement; OR 1.06 per patch used; CI: 95% CI: 1.03-1.08

Greater adherence to transdermal nicotine patch use was significantly associated with higher odds of achieving smoking abstinence at end of treatment.

Effect: improvement; OR 1.06 per patch used; CI: 95% CI: 1.03-1.08

Greater adherence to transdermal nicotine patch use was significantly associated with higher odds of achieving smoking abstinence at end of treatment.

Effect: improvement; OR 1.06 per patch used; CI: 95% CI: 1.03-1.08

Greater adherence to transdermal nicotine patch use was significantly associated with higher odds of achieving smoking abstinence at end of treatment.

Effect: improvement; OR 1.06 per patch used; CI: 95% CI: 1.03-1.08

Greater adherence to transdermal nicotine patch use was significantly associated with higher odds of achieving smoking abstinence at end of treatment.

Effect: improvement; OR 1.06 per patch used; CI: 95% CI: 1.03-1.08

Greater adherence to transdermal nicotine patch use was significantly associated with higher odds of achieving smoking abstinence at end of treatment.

Effect: improvement; OR 1.06 per patch used; CI: 95% CI: 1.03-1.08

Greater adherence to transdermal nicotine patch use was significantly associated with higher odds of achieving smoking abstinence at end of treatment.

Effect: improvement; OR 1.06 per patch used; CI: 95% CI: 1.03-1.08

Greater adherence to transdermal nicotine patch use was significantly associated with higher odds of achieving smoking abstinence at end of treatment.

Effect: improvement; OR 1.06 per patch used; CI: 95% CI: 1.03-1.08

Greater adherence to transdermal nicotine patch use was significantly associated with higher odds of achieving smoking abstinence at end of treatment.

Effect: improvement; OR 1.06 per patch used; CI: 95% CI: 1.03-1.08

Greater adherence to transdermal nicotine patch use was significantly associated with higher odds of achieving smoking abstinence at end of treatment.

Effect: improvement; OR 1.06 per patch used; CI: 95% CI: 1.03-1.08

Greater adherence to transdermal nicotine patch use was significantly associated with higher odds of achieving smoking abstinence at end of treatment.

Effect: improvement; OR 1.06 per patch used; CI: 95% CI: 1.03-1.08

Greater adherence to transdermal nicotine patch use was significantly associated with higher odds of achieving smoking abstinence at end of treatment.

Effect: improvement; OR 1.06 per patch used; CI: 95% CI: 1.03-1.08

Greater adherence to transdermal nicotine patch use was significantly associated with higher odds of achieving smoking abstinence at end of treatment.

Effect: improvement; OR 1.06 per patch used; CI: 95% CI: 1.03-1.08

Greater adherence to transdermal nicotine patch use was significantly associated with higher odds of achieving smoking abstinence at end of treatment.

Effect: improvement; OR 1.06 per patch used; CI: 95% CI: 1.03-1.08

Greater adherence to transdermal nicotine patch use was significantly associated with higher odds of achieving smoking abstinence at end of treatment.

Effect: improvement; OR 1.06 per patch used; CI: 95% CI: 1.03-1.08

Greater adherence to transdermal nicotine patch use was significantly associated with higher odds of achieving smoking abstinence at end of treatment.

Effect: improvement; OR 1.06 per patch used; CI: 95% CI: 1.03-1.08

Greater adherence to transdermal nicotine patch use was significantly associated with higher odds of achieving smoking abstinence at end of treatment.

Effect: improvement; OR 1.06 per patch used; CI: 95% CI: 1.03-1.08

Greater adherence to transdermal nicotine patch use was significantly associated with higher odds of achieving smoking abstinence at end of treatment.

Effect: improvement; OR 1.06 per patch used; CI: 95% CI: 1.03-1.08

Greater adherence to transdermal nicotine patch use was significantly associated with higher odds of achieving smoking abstinence at end of treatment.

Effect: improvement; OR 1.06 per patch used; CI: 95% CI: 1.03-1.08

Greater adherence to transdermal nicotine patch use was significantly associated with higher odds of achieving smoking abstinence at end of treatment.

Effect: improvement; OR 1.06 per patch used; CI: 95% CI: 1.03-1.08

Greater adherence to transdermal nicotine patch use was significantly associated with higher odds of achieving smoking abstinence at end of treatment.

Effect: improvement; OR 1.06 per patch used; CI: 95% CI: 1.03-1.08